TSB and TTP regimens combined with TACE for unresectable hepatocellular carcinoma remain a subject of ongoing clinical inquiry and evaluation.
Absolute Event Rate: 0% vs 0%
Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
Wang et al. (Mon,) reported a other. TSB and TTP regimens combined with TACE for unresectable hepatocellular carcinoma remain a subject of ongoing clinical inquiry and evaluation.